Calcimedica Inc (CALC)

$0.63 -0.02 (-2.33%)
Market Cap 9.75M
Revenue (ttm) 0.00
Net Income (ttm) -29.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.27
Volume 115,800
Avg Vol 208,470
Day's Range N/A - N/A
Shares Out 15.80M
Stochastic %K 44%
Beta 0.85
Analysts Strong Sell
Price Target $10.33

Company Profile

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 952 5500
Address:
505 Coast Boulevard South, Suite 307, La Jolla, United States
SUGONDEEZNUTS
SUGONDEEZNUTS May. 21 at 10:45 AM
$CALC SCHEDULE 13G/A filed yesterday
1 · Reply
Action80gr
Action80gr May. 21 at 3:55 AM
$CALC https://it.investing.com/news/stock-market-news/jpmorgan-vede-il-settore-biotech-a-un-punto-di-svolta-ripristinata-la-copertura-su-14-aziende-3381672
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 6:06 PM
$CALC There is nothing we can do about this manipulation! We have to be patient. You can buy and wait. Now on, I will only add around 62cents. They will try to lower on that area again.
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 5:11 PM
$CALC There is a seller that hates money on this ticker:)) while buyers wants to pay more, he right away sells for cheaper and cheaper. We are almost there in my opinion. I don’t mind this SP at all. I will be adding every day.
1 · Reply
66Caprice327
66Caprice327 May. 20 at 5:07 PM
$CALC Without news, any price spikes are a ploy to draw profit taking for liquidity.
0 · Reply
SUGONDEEZNUTS
SUGONDEEZNUTS May. 20 at 5:01 PM
$CALC
0 · Reply
keokeostwiz
keokeostwiz May. 20 at 4:54 PM
$CALC Any kind of volume and 1.25 appears......JMO
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 4:51 PM
$CALC Added more, this is about to break out with news and I belive we should expect something after memorial day week at least!
0 · Reply
Icemanja
Icemanja May. 20 at 2:38 PM
$CALC Same thing everyday , close red by the end of day. Stuck in the mud
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 19 at 8:44 PM
$CALC RSI: 59.95, MACD: -0.0050 Vol: 0.03, MA20: 0.61, MA50: 0.64 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on CALC
CalciMedica Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 9 days ago

CalciMedica Quarterly report: Q1 2026

CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

May 12, 2026, 7:00 AM EDT - 9 days ago

CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

CalciMedica price target lowered to $10 from $20 at Oppenheimer

2026-03-05T13:27:54.000Z - 2 months ago

CalciMedica price target lowered to $10 from $20 at Oppenheimer

CalciMedica files $125M mixed securities shelf

2026-03-03T22:00:59.000Z - 2 months ago

CalciMedica files $125M mixed securities shelf

CalciMedica Reports 2025 Financial Results and Provides Clinical Updates

Mar 3, 2026, 7:00 AM EST - 2 months ago

CalciMedica Reports 2025 Financial Results and Provides Clinical Updates

CalciMedica Registration statement: Registration Filing

Mar 3, 2026, 7:00 AM EST - 2 months ago

CalciMedica Registration statement: Registration Filing

CalciMedica downgraded to Neutral from Buy at H.C. Wainwright

2026-01-29T11:11:18.000Z - 4 months ago

CalciMedica downgraded to Neutral from Buy at H.C. Wainwright

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

Jan 28, 2026, 7:00 AM EST - 4 months ago

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

CalciMedica Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 6 months ago

CalciMedica Registration statement: Registration Filing

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Nov 12, 2025, 7:01 AM EST - 6 months ago

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

Nov 12, 2025, 7:00 AM EST - 6 months ago

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

Nov 10, 2025, 7:00 AM EST - 6 months ago

CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™

Oct 14, 2025, 7:00 AM EDT - 7 months ago

CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 7:00 AM EDT - 9 months ago

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Aug 12, 2025, 7:00 AM EDT - 10 months ago

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 7:00 AM EDT - 11 months ago

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

Jun 25, 2025, 7:00 AM EDT - 11 months ago

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

Jun 12, 2025, 7:00 AM EDT - 1 year ago

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

CalciMedica Proxy statement: Proxy Filing

Jun 9, 2025, 8:00 AM EDT - 1 year ago

CalciMedica Proxy statement: Proxy Filing

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

May 14, 2025, 7:00 AM EDT - 1 year ago

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

CalciMedica Proxy statement: Proxy Filing

CalciMedica Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

CalciMedica Proxy statement: Proxy Filing

CalciMedica Announces Presentations at Upcoming Medical Meetings

Apr 17, 2025, 7:00 AM EDT - 1 year ago

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

Apr 1, 2025, 7:00 AM EDT - 1 year ago

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

Mar 27, 2025, 7:00 AM EDT - 1 year ago

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Secures Credit Facility for Up to $32.5 Million

Mar 5, 2025, 7:00 AM EST - 1 year ago

CalciMedica Secures Credit Facility for Up to $32.5 Million

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

Mar 4, 2025, 7:00 AM EST - 1 year ago

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

Feb 19, 2025, 7:00 AM EST - 1 year ago

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

Jan 14, 2025, 7:00 AM EST - 1 year ago

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 8:00 AM EST - 1 year ago

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

Nov 13, 2024, 7:00 AM EST - 1 year ago

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

Nov 7, 2024, 7:00 AM EST - 1 year ago

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CalciMedica Announces Pricing of Public Offering of Common Stock

Oct 30, 2024, 10:11 PM EDT - 1 year ago

CalciMedica Announces Pricing of Public Offering of Common Stock

CalciMedica Announces Proposed Public Offering of Common Stock

Oct 30, 2024, 4:50 PM EDT - 1 year ago

CalciMedica Announces Proposed Public Offering of Common Stock

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

Oct 30, 2024, 7:00 AM EDT - 1 year ago

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Oct 28, 2024, 4:05 PM EDT - 1 year ago

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

Oct 16, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024, 8:00 AM EDT - 1 year ago

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

Aug 12, 2024, 4:10 PM EDT - 1 year ago

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Proxy statement: Proxy Filing

Jul 16, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Proxy statement: Proxy Filing

CalciMedica Proxy statement: Proxy Filing

Jul 16, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Proxy statement: Proxy Filing

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

Jul 9, 2024, 7:30 AM EDT - 2 years ago

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

Jul 8, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

CalciMedica Set to Join Russell Microcap® Index

Jul 1, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Set to Join Russell Microcap® Index

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Jun 27, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Jun 26, 2024, 4:05 PM EDT - 2 years ago

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

May 13, 2024, 4:05 PM EDT - 2 years ago

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Apr 24, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

Mar 28, 2024, 7:00 AM EDT - 2 years ago

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

Mar 13, 2024, 8:00 AM EDT - 2 years ago

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

Feb 28, 2024, 6:57 PM EST - 2 years ago

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

Feb 13, 2024, 8:00 AM EST - 2 years ago

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 7, 2024, 4:05 PM EST - 2 years ago

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CalciMedica Registration statement: Registration Filing

Jan 31, 2024, 7:00 AM EST - 2 years ago

CalciMedica Registration statement: Registration Filing

CalciMedica Announces Private Placement of up to Approximately $55 Million

Jan 22, 2024, 8:00 AM EST - 2 years ago

CalciMedica Announces Private Placement of up to Approximately $55 Million

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Nov 9, 2023, 7:00 AM EST - 2 years ago

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

Nov 2, 2023, 9:15 AM EDT - 2 years ago

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

CalciMedica Announces Upcoming Presentations and Events in September

Sep 6, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces Upcoming Presentations and Events in September

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

Aug 31, 2023, 7:30 AM EDT - 2 years ago

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

CalciMedica Registration statement: Registration Filing

Aug 11, 2023, 8:00 AM EDT - 3 years ago

CalciMedica Registration statement: Registration Filing

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Aug 9, 2023, 7:30 AM EDT - 3 years ago

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

SUGONDEEZNUTS
SUGONDEEZNUTS May. 21 at 10:45 AM
$CALC SCHEDULE 13G/A filed yesterday
1 · Reply
Action80gr
Action80gr May. 21 at 3:55 AM
$CALC https://it.investing.com/news/stock-market-news/jpmorgan-vede-il-settore-biotech-a-un-punto-di-svolta-ripristinata-la-copertura-su-14-aziende-3381672
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 6:06 PM
$CALC There is nothing we can do about this manipulation! We have to be patient. You can buy and wait. Now on, I will only add around 62cents. They will try to lower on that area again.
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 5:11 PM
$CALC There is a seller that hates money on this ticker:)) while buyers wants to pay more, he right away sells for cheaper and cheaper. We are almost there in my opinion. I don’t mind this SP at all. I will be adding every day.
1 · Reply
66Caprice327
66Caprice327 May. 20 at 5:07 PM
$CALC Without news, any price spikes are a ploy to draw profit taking for liquidity.
0 · Reply
SUGONDEEZNUTS
SUGONDEEZNUTS May. 20 at 5:01 PM
$CALC
0 · Reply
keokeostwiz
keokeostwiz May. 20 at 4:54 PM
$CALC Any kind of volume and 1.25 appears......JMO
0 · Reply
mrtmermer80
mrtmermer80 May. 20 at 4:51 PM
$CALC Added more, this is about to break out with news and I belive we should expect something after memorial day week at least!
0 · Reply
Icemanja
Icemanja May. 20 at 2:38 PM
$CALC Same thing everyday , close red by the end of day. Stuck in the mud
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 19 at 8:44 PM
$CALC RSI: 59.95, MACD: -0.0050 Vol: 0.03, MA20: 0.61, MA50: 0.64 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Super_Marioo
Super_Marioo May. 19 at 7:49 PM
$CALC - 4 months of flat as a pan cake :(
0 · Reply
mrtmermer80
mrtmermer80 May. 19 at 6:44 PM
$CALC Wow, someone is keep buying 50sharws at a time! Getting crazy!
0 · Reply
j0shyuaa
j0shyuaa May. 19 at 5:50 PM
$CALC @Steve_TheBull_Rogers i know you’re a bio guy. What’s your thoughts on this?
1 · Reply
keokeostwiz
keokeostwiz May. 19 at 2:52 PM
$CALC 15k BUY at .64....MM drops the ASK to .63....how long can they hold this down
1 · Reply
Eli18222
Eli18222 May. 18 at 11:02 AM
$CALC will be a good day 🌞
0 · Reply
mrtmermer80
mrtmermer80 May. 17 at 12:09 PM
$CALC if AUXORA is good and accepted, we are sitting on gold mine!!!
3 · Reply
keokeostwiz
keokeostwiz May. 15 at 8:16 PM
$CALC Institutions took advantage of a terrible overall market day and spent the time manipulating share price to accumulate cheap shares......this presence reflects interest and ambition of better days ahead as CALC armed with a fabulous pipeline moves toward P3 launch exposing the efficacy, safety and acceptance of AUXORA as a viable therapy for treatment of the unmet medical need areas of AP and AKI....JMO
0 · Reply
keokeostwiz
keokeostwiz May. 15 at 4:42 PM
$CALC 15k bought at .7210 followed immediately with 100 shares at .6984.......just a matter of time and volume to fly
1 · Reply
keokeostwiz
keokeostwiz May. 15 at 4:33 PM
$CALC 10k bought at .7210.....100 shares follows at .7043......manipulation trying to hold price down.....7.20-.46 due to BS safety charges.....RETRACE under construction
0 · Reply
MUBSN
MUBSN May. 15 at 4:08 PM
$CALC ready?
0 · Reply
keokeostwiz
keokeostwiz May. 15 at 3:25 PM
$CALC A spark may introduce a FIRE.....heating UP
1 · Reply
Super_Marioo
Super_Marioo May. 14 at 7:49 PM
$CALC -well so far so good. let’s see if it continues.
0 · Reply